Suphamai Bunnapradist

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi request reprint Mycophenolate mofetil dose reductions and discontinuations after gastrointestinal complications are associated with renal transplant graft failure
    Suphamai Bunnapradist
    Multi Organ Transplant Program, Cedars Sinai Medical Center, Los Angeles, CA, USA
    Transplantation 82:102-7. 2006
  2. pmc Conversion from twice-daily tacrolimus to once-daily extended release tacrolimus (LCPT): the phase III randomized MELT trial
    S Bunnapradist
    David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    Am J Transplant 13:760-9. 2013
  3. doi request reprint The impact of pre-transplant dialysis on simultaneous pancreas-kidney versus living donor kidney transplant outcomes
    Alexander C Wiseman
    Transplant Center, Division of Renal Diseases and Hypertension, University of Colorado Denver, Aurora, CO, USA
    Nephrol Dial Transplant 28:1047-58. 2013
  4. ncbi request reprint Evaluation of adult kidney transplant candidates
    Suphamai Bunnapradist
    Division of Nephrology, UCLA Medical Center, Los Angeles, USA
    Am J Kidney Dis 50:890-8. 2007
  5. doi request reprint Impact of gastrointestinal-related side effects on mycophenolate mofetil dosing and potential therapeutic strategies
    Suphamai Bunnapradist
    David Geffen School of Medicine, Department of Medicine, Division of Nephrology, Los Angeles, CA 90095 7306, USA
    Clin Transplant 22:815-21. 2008
  6. doi request reprint Effects of antibody induction on transplant outcomes in human leukocyte antigen zero-mismatch deceased donor kidney recipients
    Hung Tien Kuo
    Division of Nephrology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    Transplantation 93:493-502. 2012
  7. pmc Living donor kidney versus simultaneous pancreas-kidney transplant in type I diabetics: an analysis of the OPTN/UNOS database
    Brian Y Young
    David Geffen School of Medicine, University of California, Los Angeles, California 90095, USA
    Clin J Am Soc Nephrol 4:845-52. 2009
  8. doi request reprint Intermediate-term outcomes associated with kidney transplantation in recipients 80 years and older: an analysis of the OPTN/UNOS database
    Edmund Huang
    Division of Nephrology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
    Transplantation 90:974-9. 2010
  9. pmc Transplant tourism in the United States: a single-center experience
    Jagbir Gill
    Division of Nephrology, David Geffen School of Medicine at University of California, Los Angeles, California, USA
    Clin J Am Soc Nephrol 3:1820-8. 2008
  10. ncbi request reprint Outcomes of kidney transplantation from older living donors to older recipients
    Jagbir Gill
    Division of Nephrology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    Am J Kidney Dis 52:541-52. 2008

Detail Information

Publications77

  1. ncbi request reprint Mycophenolate mofetil dose reductions and discontinuations after gastrointestinal complications are associated with renal transplant graft failure
    Suphamai Bunnapradist
    Multi Organ Transplant Program, Cedars Sinai Medical Center, Los Angeles, CA, USA
    Transplantation 82:102-7. 2006
    ..Little is known of the association between MMF dose reductions and discontinuations following GI complications and graft survival...
  2. pmc Conversion from twice-daily tacrolimus to once-daily extended release tacrolimus (LCPT): the phase III randomized MELT trial
    S Bunnapradist
    David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    Am J Transplant 13:760-9. 2013
    ..LCPT may offer a safe and effective alternative for converting patients to a once-daily formulation. Compared to currently available tacrolimus formulation, LCPT requires lower doses to achieve target trough levels...
  3. doi request reprint The impact of pre-transplant dialysis on simultaneous pancreas-kidney versus living donor kidney transplant outcomes
    Alexander C Wiseman
    Transplant Center, Division of Renal Diseases and Hypertension, University of Colorado Denver, Aurora, CO, USA
    Nephrol Dial Transplant 28:1047-58. 2013
    ..Here, we report the impact of pre-transplant dialysis on patient and graft survival of type 1 diabetic recipients of either a simultaneous pancreas-kidney (SPK) or living donor kidney (LDK) transplant...
  4. ncbi request reprint Evaluation of adult kidney transplant candidates
    Suphamai Bunnapradist
    Division of Nephrology, UCLA Medical Center, Los Angeles, USA
    Am J Kidney Dis 50:890-8. 2007
  5. doi request reprint Impact of gastrointestinal-related side effects on mycophenolate mofetil dosing and potential therapeutic strategies
    Suphamai Bunnapradist
    David Geffen School of Medicine, Department of Medicine, Division of Nephrology, Los Angeles, CA 90095 7306, USA
    Clin Transplant 22:815-21. 2008
    ..In conclusion, monitoring of GI complications is essential following renal transplantation, and maintaining adequate mycophenolic acid exposure should be a priority when considering treatment options...
  6. doi request reprint Effects of antibody induction on transplant outcomes in human leukocyte antigen zero-mismatch deceased donor kidney recipients
    Hung Tien Kuo
    Division of Nephrology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    Transplantation 93:493-502. 2012
    ..We aimed to investigate the impact of antibody induction on outcomes in human leukocyte antigen (HLA) 0-mismatched deceased donor kidney recipients...
  7. pmc Living donor kidney versus simultaneous pancreas-kidney transplant in type I diabetics: an analysis of the OPTN/UNOS database
    Brian Y Young
    David Geffen School of Medicine, University of California, Los Angeles, California 90095, USA
    Clin J Am Soc Nephrol 4:845-52. 2009
    ..The authors compared outcomes of kidney transplant recipients with type I diabetes using data from the Organ Procurement and Transplant Network/United Network for Organ Sharing...
  8. doi request reprint Intermediate-term outcomes associated with kidney transplantation in recipients 80 years and older: an analysis of the OPTN/UNOS database
    Edmund Huang
    Division of Nephrology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
    Transplantation 90:974-9. 2010
    ..Using Organ Procurement and Transplantation Network/United Network of Organ Sharing data, outcomes of recipients 80 years and older were evaluated...
  9. pmc Transplant tourism in the United States: a single-center experience
    Jagbir Gill
    Division of Nephrology, David Geffen School of Medicine at University of California, Los Angeles, California, USA
    Clin J Am Soc Nephrol 3:1820-8. 2008
    ..Median follow-up time was 487 d (range 68 to 3056)...
  10. ncbi request reprint Outcomes of kidney transplantation from older living donors to older recipients
    Jagbir Gill
    Division of Nephrology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    Am J Kidney Dis 52:541-52. 2008
    ..As waiting times for a deceased donor kidney increase, these older candidates are disadvantaged by rapidly deteriorating health, often resulting in death or removal from the wait list before transplantation...
  11. doi request reprint Impact of Epstein-Barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients
    Marcelo Santos Sampaio
    Mendez National Institute of Transplantation, Los Angeles, CA, USA
    Nephrol Dial Transplant 27:2971-9. 2012
    ..Post-transplant lymphoproliferative disorder (PTLD) is a serious complication of transplantation...
  12. doi request reprint Alemtuzumab versus interleukin-2 receptor antibodies induction in living donor kidney transplantation
    Marcelo S Sampaio
    Division of Nephrology, Kidney and Pancreas Transplant Program, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    Transplantation 88:904-10. 2009
    ..We aimed to compare posttransplantation outcomes between alemtuzumab and interleukin-2 receptor antibodies (IL-2RA) in living donor kidney transplant recipients in the United States...
  13. ncbi request reprint Pancreas after living donor kidney versus simultaneous pancreas-kidney transplant: an analysis of the organ procurement transplant network/united network of organ sharing database
    Neda Poommipanit
    Division of Nephrology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA
    Transplantation 89:1496-503. 2010
    ..We retrospectively compared the outcomes of SPKT versus PALK...
  14. doi request reprint Risk factors for new-onset diabetes mellitus in adult liver transplant recipients, an analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing database
    Hung Tien Kuo
    Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA
    Transplantation 89:1134-40. 2010
    ..Identified risk factors for NODM in liver transplantation were similar to that in kidney transplantation. Some of the identified factors are potentially modifiable, including obesity and the choice of immunosuppressive regimens...
  15. pmc Impact of pre-existing hepatitis B infection on the outcomes of kidney transplant recipients in the United States
    Pavani Naini Reddy
    Division of Nephrology, Kidney and Pancreas Transplant Program, David Geffen School of Medicine at UCLA, Los Angeles, California, USA
    Clin J Am Soc Nephrol 6:1481-7. 2011
    ..Pre-existing hepatitis B virus (HBV) infection has been associated in inferior renal transplant outcomes. We examined outcomes of HBV+ renal recipients in a more recent era with availability of oral anti-viral agents...
  16. doi request reprint Outcomes of dual adult kidney transplants in the United States: an analysis of the OPTN/UNOS database
    Jagbir Gill
    David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA
    Transplantation 85:62-8. 2008
    ..There are limited data comparing outcomes of DKT to single kidney ECD transplants, making it unclear where DKT fits in the current allocation scheme. Our purpose was to compare outcomes of DKT and ECD transplants in the United States...
  17. doi request reprint Cytomegalovirus serostatus pairing and deceased donor kidney transplant outcomes in adult recipients with antiviral prophylaxis
    Hung Tien Kuo
    Division of Nephrology, Kidney and Pancreas Transplant Program, David Geffen School of Medicine at University of California, Los Angeles, CA, USA
    Transplantation 90:1091-8. 2010
    ....
  18. doi request reprint Obesity was associated with inferior outcomes in simultaneous pancreas kidney transplant
    Marcelo Santos Sampaio
    Division of Nephrology, Kidney and Pancreas Transplant Program, David Geffen School of Medicine at UCLA, Los Angeles, CA USA
    Transplantation 89:1117-25. 2010
    ..CONCLUSION.: Obesity in SPK recipients was associated with increased risk of posttransplant complications, pancreas and kidney graft loss, and patient death...
  19. ncbi request reprint Patient and graft outcomes from deceased kidney donors age 70 years and older: an analysis of the Organ Procurement Transplant Network/United Network of Organ Sharing database
    Disaya Chavalitdhamrong
    Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA
    Transplantation 85:1573-9. 2008
    ..We examined patient and graft outcomes of renal transplant from expanded criteria donors (ECDs) aged 70 years and older, using the Organ Procurement Transplant Network/United Network of Organ Sharing database...
  20. doi request reprint Transplantation with pancreas after living donor kidney vs. living donor kidney alone in type 1 diabetes mellitus recipients
    Marcelo Santos Sampaio
    David Geffen School of Medicine at UCLA, Kidney and Pancreas Transplant Program, Los Angeles, CA, USA
    Clin Transplant 24:812-20. 2010
    ..Pancreas transplant in the first year after kidney transplant was associated with a trend toward better long-term patient survival...
  21. doi request reprint Posttransplant malignancies in solid organ adult recipients: an analysis of the U.S. National Transplant Database
    Marcelo Santos Sampaio
    Mendez National Institute of Transplantation, Los Angeles, CA 90057, USA
    Transplantation 94:990-8. 2012
    ..De novo posttransplant malignancy (PTM) is a serious complication of transplantation. Incidences may vary among solid organ transplantations (SOTs) and may take to particular screening recommendations and posttransplantation care...
  22. doi request reprint Association of immunosuppressive maintenance regimens with posttransplant lymphoproliferative disorder in kidney transplant recipients
    Marcelo Santos Sampaio
    Mendez National Institute of Transplantation, Los Angeles, CA, USA
    Transplantation 93:73-81. 2012
    ..The association of immunosuppressive regimens (ISRs) with posttransplant lymphoproliferative disorder (PTLD) may be related with the Epstein-Barr virus (EBV) recipient serostatus...
  23. doi request reprint Pretransplant risk factors for new-onset diabetes mellitus after transplant in pediatric liver transplant recipients
    Hung Tien Kuo
    Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA
    Liver Transpl 16:1249-56. 2010
    ..Underlying liver disease of cystic fibrosis, primary sclerosing cholangitis, and acute hepatic necrosis are independent risk factors for NODAT in pediatric liver transplant recipients...
  24. doi request reprint Kidney transplant outcomes in patients with Fabry disease
    Tariq Shah
    St Vincent Medical Center National Institute of Transplantation, Los Angeles, CA, USA
    Transplantation 87:280-5. 2009
    ..Fabry disease is a rare but important cause of end-stage renal disease (ESRD) among young men. Postkidney transplantation outcomes among patients with Fabry disease remain controversial...
  25. doi request reprint Incidence and risk factors for diarrhea following kidney transplantation and association with graft loss and mortality
    Suphamai Bunnapradist
    David Geffen School of Medicine, University of California, Los Angeles, CA, USA
    Am J Kidney Dis 51:478-86. 2008
    ..Gastrointestinal complications after kidney transplantation are associated with inferior graft outcomes. We examined the incidence, risk factors, and outcomes of posttransplantation diarrhea...
  26. doi request reprint Influence of preexisting hepatitis C virus antibody positivity in simultaneous pancreas-kidney transplant recipients
    Maria Miguel
    Division of Nephrology, Kidney and Pancreas Transplant Program, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA
    Transplantation 90:61-7. 2010
    ..We evaluated the effect of preexisting HCV infection on patient and graft survival in simultaneous pancreas-kidney transplant (SPKT) recipients in the United States...
  27. doi request reprint Zero-mismatch deceased-donor kidney versus simultaneous pancreas-kidney transplantation
    Mandana Kamgar
    Division of Nephrology, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, CA, USA
    Transplantation 94:822-9. 2012
    ..In this study, we compared the outcomes of T1DM recipients using data from the Organ Procurement and Transplant Network/United Network for Organ Sharing...
  28. doi request reprint Risk factors for development of new-onset diabetes mellitus after transplant in adult lung transplant recipients
    Xiaoyi Ye
    Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA
    Clin Transplant 25:885-91. 2011
    ..Some of the risk factors for NODAT after lung transplant are similar to those reported in other solid-organ transplants. Cystic fibrosis is a strong risk factor for development of NODAT after lung transplant...
  29. ncbi request reprint Alemtuzumab induction in deceased donor kidney transplantation
    Edmund Huang
    Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA
    Transplantation 84:821-8. 2007
    ..Herein is a report of graft outcomes associated with alemtuzumab induction from the Organ Procurement and Transplantation Network/United Network for Organ Sharing database...
  30. ncbi request reprint Risk factors for development of new-onset diabetes mellitus in adult heart transplant recipients
    Xiaoyi Ye
    Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA
    Transplantation 89:1526-32. 2010
    ....
  31. doi request reprint The evolving notion of "senior" kidney transplant recipients
    Tariq Shah
    National Institute of Transplantation, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA
    Clin Transplant 22:794-802. 2008
    ..However, both graft and patient survival rates decreased with increasing age. Although a small fraction was selected, and survival rates were lower, patients older than 80 yr received kidney transplants...
  32. doi request reprint Associations of pretransplant diabetes mellitus, new-onset diabetes after transplant, and acute rejection with transplant outcomes: an analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing (OPTN/UNOS) database
    Hung Tien Kuo
    Nephrology, UCLA Medical Center, Los Angeles, CA, USA
    Am J Kidney Dis 56:1127-39. 2010
    ..Our objective was to investigate the joint associations of diabetes (pretransplant diabetes and new-onset diabetes after transplant) and acute rejection with transplant outcomes in a recent transplant cohort...
  33. ncbi request reprint Analysis of the United Network for Organ Sharing database comparing renal allografts and patient survival in combined liver-kidney transplantation with the contralateral allografts in kidney alone or kidney-pancreas transplantation
    Tse Ling Fong
    USC Center for Liver Disease, University of Southern California, Keck School of Medicine, Los Angeles, CA 90033, USA
    Transplantation 76:348-53. 2003
    ....
  34. doi request reprint Multivariate analysis of antibody induction therapy and their associated outcomes in live donor kidney transplantation in the recent era
    Sina Emami
    Division of Nephrology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA
    Clin Transplant 26:351-8. 2012
    ....
  35. doi request reprint Induction therapy in pediatric kidney transplant recipients discharged with a triple drug immunosuppressive regimen
    Marcelo S Sampaio
    David Geffen School of Medicine at UCLA, Kidney and Pancreas Transplant Program, Los Angeles, CA, USA
    Pediatr Transplant 14:770-8. 2010
    ..Neither THY nor IL-2RA was associated with reduced rejection episodes. The use of induction therapy was not associated with improvement in three-yr graft survival...
  36. ncbi request reprint Co-infection of polyomavirus-BK and cytomegalovirus in renal transplant recipients
    Mieko Toyoda
    Transplant Immunology Laboratory, Ahmanson Pediatric Center, Steven Spielberg Pediatric Research Laboratories, Cedars Sinai Medical Center University of California, Los Angeles, 90048, USA
    Transplantation 80:198-205. 2005
    ..Polyomavirus-BK (BK) is a significant cause of allograft dysfunction in renal transplant recipients. Cytomegalovirus (CMV) and BK infection are thought to be possible risk factors for one another, but no supporting data are yet available...
  37. doi request reprint Improved survival among sickle cell kidney transplant recipients in the recent era
    Edmund Huang
    Division of Nephrology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA
    Nephrol Dial Transplant 28:1039-46. 2013
    ..We examined whether survival has improved among SCD recipients in the current era...
  38. pmc Outcomes of simultaneous pancreas-kidney transplantation in type 2 diabetic recipients
    Marcelo Santos Sampaio
    Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California 90024, USA
    Clin J Am Soc Nephrol 6:1198-206. 2011
    ..Type 2 diabetic patients with end-stage renal disease may receive a simultaneous pancreas-kidney (SPK) transplant. However, outcomes are not well described. Risks for death and graft failure were examined in SPK type 2 diabetic recipients...
  39. ncbi request reprint HBV infection in patients with end-stage renal disease
    Fabrizio Fabrizi
    Center for Liver and Kidney Diseases and Transplantation, Cedars Sinai Medical Center and Division of Digestive Diseases, UCLA School of Medicine, Los Angeles, California 90048, USA
    Semin Liver Dis 24:63-70. 2004
    ..Liver biopsy prior to renal transplantation is crucial in order to identify and exclude patients with advanced fibrosis or even cirrhosis...
  40. ncbi request reprint Treatment of chronic viral hepatitis in patients with renal disease
    Fabrizio Fabrizi
    Center for Liver and Kidney Diseases and Transplantation, Cedars Sinai Medical Center, University of California Los Angeles School of Medicine, 8635 West Third Street, Suite 590W, Los Angeles, CA 90048, USA
    Gastroenterol Clin North Am 33:655-70, xi. 2004
    ..This article aims to address the current therapeutic options for patients with renal disease and chronic viral hepatitis...
  41. ncbi request reprint Donor biopsy and kidney transplant outcomes: an analysis using the Organ Procurement and Transplantation Network/United Network for Organ Sharing (OPTN/UNOS) database
    Meera Bajwa
    Division of Nephrology, University of California, Los Angeles, CA, USA
    Transplantation 84:1399-405. 2007
    ..This study compared graft survival with the degree of glomerulosclerosis found on donor biopsy. We also examined the agreement in degree of glomerulosclerosis between paired kidneys...
  42. ncbi request reprint Graft survival following living-donor renal transplantation: a comparison of tacrolimus and cyclosporine microemulsion with mycophenolate mofetil and steroids
    Suphamai Bunnapradist
    Multiorgan Transplant Program, Cedars Sinai Medical Center, Los Angeles, CA, USA
    Transplantation 76:10-5. 2003
    ..This study analyses 2-year graft survival using tacrolimus (tac) or cyclosporine (CsA) with mycophenolate mofetil (MMF) and steroids...
  43. doi request reprint Outcomes of preemptive kidney with or without subsequent pancreas transplant compared with preemptive simultaneous pancreas/kidney transplantation
    Edmund Huang
    Division of Nephrology, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA
    Transplantation 92:1115-22. 2011
    ..Whether this association remains and how outcomes compare to deceased donor kidney (DDK) transplantation in the preemptive setting are unknown...
  44. doi request reprint Risk factors for development of new-onset diabetes mellitus in pediatric renal transplant recipients: an analysis of the OPTN/UNOS database
    Hung Tien Kuo
    Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA
    Transplantation 89:434-9. 2010
    ....
  45. pmc Association of pre-transplant erythropoiesis-stimulating agent responsiveness with post-transplant outcomes
    Miklos Z Molnar
    Harold Simmons Center for Chronic Disease Research and Epidemiology, Los Angeles Biomedical Research Institute, Harbor UCLA Medical Center, Torrance, CA, USA
    Nephrol Dial Transplant 27:3345-51. 2012
    ..The role of pre-transplant erythropoiesis-stimulating agent (ESA) responsiveness in affecting post-transplant outcomes is not clear...
  46. doi request reprint Outcomes of renal transplantation in recipients with Wegener's granulomatosis
    Jenny Shen
    David Geffen School of Medicine at UCLA, Kidney and Pancreas Transplant Program, Los Angeles, CA, USA
    Clin Transplant 25:380-7. 2011
    ..This study supports the notion that renal transplantation is an effective treatment option for patients with ESRD secondary to WG. They fare similarly, if not better, than other patients...
  47. ncbi request reprint Is there a reversal of reverse epidemiology in renal transplant recipients?
    Disaya Chavalitdhamrong
    Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California, USA
    Semin Dial 20:544-8. 2007
    ..Because definitive evidence on optimal intervention is lacking, population-specific clinical trials are needed to define optimum targets for treatment of these risk factors in maintenance dialysis patients and RTR separately...
  48. ncbi request reprint Can aminotransferase-to-platelet ratio index and other non-invasive markers effectively reduce liver biopsies for renal transplant evaluation of hepatitis C virus-positive patients?
    Yan Jiang
    Division of Nephrology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA
    Nephrol Dial Transplant 29:1247-52. 2014
    ..Can these be used to effectively decrease the number of biopsies done in these patients being evaluated for transplantation?..
  49. ncbi request reprint Lamivudine for the treatment of hepatitis B virus-related liver disease after renal transplantation: meta-analysis of clinical trials
    Fabrizio Fabrizi
    Center for Liver and Kidney Diseases and Transplantation, Cedars Sinai Medical Center, Los Angeles, CA, USA
    Transplantation 77:859-64. 2004
    ..Numerous reports have appeared on lamivudine use for the treatment of hepatitis B virus (HBV) infection after renal transplantation (RT). However, the efficacy and safety of lamivudine after RT remain unclear...
  50. ncbi request reprint Safety and adverse events profiles of intravenous gammaglobulin products used for immunomodulation: a single-center experience
    Ashley A Vo
    Comprehensive Transplant Center, Cedars Sinai Medical Center, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California 90048, USA
    Clin J Am Soc Nephrol 1:844-52. 2006
    ..Gamimune-N 10% and other IVIg products were frequently associated with headaches. Administration of IVIg to patients who are on hemodialysis seems to be safe and effective...
  51. doi request reprint Cause of death with graft function among renal transplant recipients in an integrated healthcare system
    Joseph Kahwaji
    Kidney and Pancreas Transplant Program, Cedars Sinai Medical Center, Los Angeles, CA, USA
    Transplantation 91:225-30. 2011
    ..We studied renal transplant recipients within an integrated healthcare system (IHS) that uses case management and electronic health records to determine mortality from CVD...
  52. ncbi request reprint Immunosuppression of the elderly kidney transplant recipient
    Gabriel M Danovitch
    Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA
    Transplantation 84:285-91. 2007
    ..Taking these factors into consideration, we propose an approach to immunosuppression in the elderly based on individual risk stratification of treatment failure and the potential for adverse events...
  53. doi request reprint Management of renal dysfunction in patients receiving a liver transplant
    Christine Lau
    Kidney and Pancreas Transplant Program, Division of Nephrology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90024, USA
    Clin Liver Dis 15:807-20. 2011
    ..An important issue is the frequent need for kidney, in addition to liver, transplantation if renal insufficiency has been persistent in a decompensated cirrhotic...
  54. ncbi request reprint Dual kidneys from marginal adult donors as a source for cadaveric renal transplantation in the United States
    Suphamai Bunnapradist
    Center for Kidney and Kidney Pancreas Transplantation, Burns Allen Research Institute, Cedars Sinai Medical Center, Los Angeles, California 90048, USA
    J Am Soc Nephrol 14:1031-6. 2003
    ..When compared with SKT with donors over 55 yr of age, DKT resulted in similar graft outcomes. These otherwise discarded kidneys should be cautiously considered as a source of marginal donors...
  55. pmc Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis
    Kamyar Kalantar-Zadeh
    Harold Simmons Center for Kidney Disease Research and Epidemiology, Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, 1124 W Carson St, C1 Annex, Torrance, CA 90509 2910, USA
    Circulation 119:671-9. 2009
    ..Volume overload in heart failure is associated with worse outcomes. We hypothesized that in hemodialysis patients, greater interdialytic fluid gain is associated with poor all-cause and cardiovascular survival...
  56. pmc Associations of pretransplant weight and muscle mass with mortality in renal transplant recipients
    Elani Streja
    Harold Simmons Center for Chronic Disease Research and Epidemiology, Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, Torrance, CA 90509 2910, USA
    Clin J Am Soc Nephrol 6:1463-73. 2011
    ....
  57. ncbi request reprint Risk factors for development of new-onset diabetes mellitus after kidney transplantation
    Tariq Shah
    National Institute of Transplantation, Los Angeles, CA, USA
    Transplantation 82:1673-6. 2006
    ....
  58. ncbi request reprint Fabry disease in a renal allograft
    Dechu P Puliyanda
    Center for Kidney Diseases, Department of Renal Pathology, Division of Medical Genetics, UCLA School of Medicine, Cedars Sinai Medical Center, Los Angeles, CA, USA
    Am J Transplant 3:1030-2. 2003
    ..Two years post-transplant the patient continues to have non-nephrotic range proteinuria with normal serum creatinine...
  59. doi request reprint Expanding the evidence base in transplantation: the complementary roles of randomized controlled trials and outcomes research
    Steven K Takemoto
    National Institute of Transplantation, S Mark Taper Foundation Transplant Center, Los Angeles, CA 90057, USA
    Transplantation 86:18-25. 2008
    ..A case is made for regulatory and reimbursement authorities to use outcomes research when making efficacy, effectiveness, and coverage decisions in transplantation...
  60. ncbi request reprint Bone and mineral disorders after kidney transplantation: therapeutic strategies
    Miklos Z Molnar
    Division of Nephrology and Hypertension, University of California Irvine Medical Center, Orange, CA, USA Department of Medicine, Division of Nephrology, University Health Network, University of Toronto, Toronto, Ontario, Canada
    Transplant Rev (Orlando) 28:56-62. 2014
    ..We also discussed the diagnostic approach; immunosuppression management and potential treatment of MBD in kidney transplant recipients. ..
  61. ncbi request reprint Cellular immune responses to cytomegalovirus in renal transplant recipients
    Raju Radha
    Transplant Immunology Laboratory, Ahmanson Pediatric Center, Steven Spielberg Pediatric Research Laboratories, Cedars Sinai Medical Center UCLA David Geffen School of Medicine, Los Angeles, CA, USA
    Am J Transplant 5:110-7. 2005
    ....
  62. ncbi request reprint Kinetics of hepatitis C virus load during hemodialysis: novel perspectives
    Fabrizio Fabrizi
    Center for Liver and Kidney Diseases and Transplantation, Cedars Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA, USA
    J Nephrol 16:467-75. 2003
    ..It is evident that additional long-term longitudinal studies by serial viral load estimations are needed to better define the dynamics of HCV viral load in the dialysis population...
  63. ncbi request reprint Kidney allograft and patient survival in type I diabetic recipients of cadaveric kidney alone versus simultaneous pancreas kidney transplants: a multivariate analysis of the UNOS database
    Suphamai Bunnapradist
    Kidney Pancreas Transplant Program, Cedars Sinai Medical Center, Los Angeles, California 90048, USA
    J Am Soc Nephrol 14:208-13. 2003
    ..This observation was explained by favorable donor and recipient factors in the SPK group. After controlling for these factors, SPK provided no protective or detrimental effect on short-term renal allograft or patient survival...
  64. ncbi request reprint Posttransplantation lymphoproliferative disorder presenting as a unilateral leg mass 10 years after kidney transplantation
    Suphamai Bunnapradist
    Center for Kidney Transplantation, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    Transplantation 74:1648-51. 2002
    ..He is currently 2 years posttreatment, with a serum creatinine of 0.8 mg/dL, on no immunosuppression...
  65. ncbi request reprint Transplanting kidneys from donors with prior hepatitis B infection: one response to the organ shortage
    Fabrizio Fabrizio
    Division of Nephrology, Dialysis and Transplantation, Maggiore Hospital, Policlinico IRCCS, Milano, Italy
    J Nephrol 15:605-13. 2002
    ..Prospective long-term studies are in progress to assess the risk of de novo HBV infection (HBsAg seroconversion) in renal transplant recipients who have not been successfully immunized with vaccine against HBV...
  66. doi request reprint Multicenter, randomized study of the use of everolimus with tacrolimus after renal transplantation demonstrates its effectiveness
    Laurence Chan
    Health Sciences Center, University of Colorado, Denver, CO 80262, USA
    Transplantation 85:821-6. 2008
    ..Clinical data are lacking concerning concomitant administration of everolimus and tacrolimus in renal transplant recipients...
  67. ncbi request reprint Health insurance considerations for adolescent transplant recipients as they transition to adulthood
    Lisa M Willoughby
    Department of Internal Medicine, Center for Outcomes Research, Saint Louis University, St Louis, MO 63104, USA
    Pediatr Transplant 11:127-31. 2007
    ..The purpose of this article was to review these and other issues pertaining to medical insurance coverage and transplantation, particularly for adolescent recipients as they transition to adulthood...
  68. ncbi request reprint Post-transplant diabetes mellitus and HCV seropositive status after renal transplantation: meta-analysis of clinical studies
    Fabrizio Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS, Milano, Italy
    Am J Transplant 5:2433-40. 2005
    ..This relationship provides one potential explanation for the adverse effects of HCV on patient and graft survival after RT...
  69. ncbi request reprint Impact of hepatitis B core antibody status on outcomes of cadaveric renal transplantation: analysis of United network of organ sharing database between 1994 and 1999
    Tse Ling Fong
    Division of Gastrointestinal and Liver Diseases, Keck School of Medicine, University of Southern California, 2011 Zonal Avenue HMR 101, Los Angeles CA 90033, USA
    Transplantation 73:85-9. 2002
    ..To address these issues, an analysis was performed using the United Network of Organ Sharing cadaveric kidney transplant database between 1994 to 1999...
  70. ncbi request reprint Treatment of hepatitis C in potential kidney and heart transplant patients
    Fabrizio Fabrizi
    Division of Liver Diseases, Mount Sinai Medical Center and School of Medicine, One Gustave L Levy Place, 1190 Fifth Ave, New York, NY 10029, USA
    Clin Liver Dis 9:487-503, viii. 2005
    ..This article reviews the literature concerning the treatment of HCV-related liver disease in renal and orthotopic heart transplantation...
  71. ncbi request reprint Outcomes of renal transplantation for recipients with lupus nephritis: analysis of the Organ Procurement and Transplantation Network database
    Suphamai Bunnapradist
    Transplantation 82:612-8. 2006
    ..Outcomes were similar regardless of type of calcineurin inhibitor, induction therapy, and time on dialysis. We conclude that lupus transplant recipients have outcomes generally equivalent to non-lupus transplant recipients...
  72. ncbi request reprint Transplantation of kidneys from HCV-positive donors: a safe strategy?
    Fabrizio Fabrizi
    Division of Nephrology, Dialysis, Transplantation, Maggiore Hospital, IRCCS, Milan, Italy
    J Nephrol 16:617-25. 2003
    ..With appropriate informed consent, use of a renal graft from an HCV positive donor may be offered to an HCV infected recipient. Additional studies are needed to clarify the link between donor HCV-positive kidneys and patient mortality...
  73. ncbi request reprint Isolated heart and liver transplant recipients are at low risk for polyomavirus BKV nephropathy
    Dechu P Puliyanda
    Center for Kidney Diseases and Transplantation, Cedars Sinai Medical Center, David Geffen School of Medicine at UCLA Los Angeles, CA 90048, USA
    Clin Transplant 20:289-94. 2006
    ..BKV viremia, rather than viruria, corresponds to BKV nephropathy. The prevalence of BKV viremia in non-renal solid organ transplants has not been systematically evaluated...
  74. ncbi request reprint Hepatitis C virus antibody status and survival after renal transplantation: meta-analysis of observational studies
    Fabrizio Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS, Milano, Italy
    Am J Transplant 5:1452-61. 2005
    ..This meta-analysis demonstrates that RT recipients with anti-HCV antibody have an increased risk of mortality and graft failure compared with HCV antibody negative patients...
  75. ncbi request reprint Treatment of active cytomegalovirus disease with oral ganciclovir in renal allograft recipients: monitoring efficacy with quantitative cytomegalovirus polymerase chain reaction
    Stanley C Jordan
    Kidney Transplant Program and Transplant Immunology, Cedars Sinai Medical Center, UCLA School of Medicine, LA, CA 90048, USA
    Am J Transplant 2:671-3. 2002
    ..Our data suggest that oral ganciclovir treatment, coupled with careful CMV-PCR monitoring, may be a reasonable alternative to long-term intravenous ganciclovir...
  76. ncbi request reprint Treatment of parvovirus B-19 (PV B-19) infection allows for successful kidney transplantation without disease recurrence
    Noha R Barsoum
    Cedars Sinai Medical Center, UCLA School of Medicine, L A, CA 90048, USA
    Am J Transplant 2:425-8. 2002
    ..Careful surveillance post transplantation is necessary to identify disease recurrence so that early treatment can be initiated...
  77. ncbi request reprint Report of the American Society of Transplantation conference on immunosuppressive drugs and the use of generic immunosuppressants
    Rita R Alloway
    University of Cincinnati, College of Medicine, Cincinnati OH, USA
    Am J Transplant 3:1211-5. 2003
    ..There was also strong support in favor of requiring studies to demonstrate bioequivalence in potentially at-risk patient populations, specifically African-Americans and pediatric patients...